Dimensional Fund Advisors
REGN icon

Dimensional Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$273M Sell
519,437
-51,750
-9% -$27.2M 0.06% 342
2025
Q1
$362M Sell
571,187
-15,838
-3% -$10M 0.09% 198
2024
Q4
$418M Buy
587,025
+16,961
+3% +$12.1M 0.1% 155
2024
Q3
$599M Sell
570,064
-16,498
-3% -$17.3M 0.15% 92
2024
Q2
$616M Sell
586,562
-2,391
-0.4% -$2.51M 0.16% 85
2024
Q1
$567M Sell
588,953
-4,569
-0.8% -$4.4M 0.15% 97
2023
Q4
$521M Sell
593,522
-25,744
-4% -$22.6M 0.15% 91
2023
Q3
$510M Buy
619,266
+6,442
+1% +$5.3M 0.17% 81
2023
Q2
$440M Sell
612,824
-20,684
-3% -$14.9M 0.14% 109
2023
Q1
$520M Sell
633,508
-1,080
-0.2% -$887K 0.18% 77
2022
Q4
$458K Sell
634,588
-15,819
-2% -$11.4K 0.14% 95
2022
Q3
$448M Buy
650,407
+18,501
+3% +$12.7M 0.17% 77
2022
Q2
$374M Buy
631,906
+46,757
+8% +$27.6M 0.13% 118
2022
Q1
$409M Buy
585,149
+82,651
+16% +$57.7M 0.13% 125
2021
Q4
$317M Buy
502,498
+98,968
+25% +$62.5M 0.1% 186
2021
Q3
$244M Buy
403,530
+83,276
+26% +$50.4M 0.08% 249
2021
Q2
$179M Buy
320,254
+70,107
+28% +$39.1M 0.06% 408
2021
Q1
$118M Buy
250,147
+13,304
+6% +$6.29M 0.04% 683
2020
Q4
$114M Buy
236,843
+11,978
+5% +$5.79M 0.04% 632
2020
Q3
$126M Buy
224,865
+8,460
+4% +$4.74M 0.05% 419
2020
Q2
$135M Buy
216,405
+7,195
+3% +$4.49M 0.06% 350
2020
Q1
$102M Buy
209,210
+2,510
+1% +$1.22M 0.05% 401
2019
Q4
$77.6M Sell
206,700
-2,192
-1% -$823K 0.03% 976
2019
Q3
$57.9M Buy
208,892
+12,301
+6% +$3.41M 0.02% 1253
2019
Q2
$61.5M Buy
196,591
+16,960
+9% +$5.31M 0.02% 1197
2019
Q1
$73.8M Sell
179,631
-3,806
-2% -$1.56M 0.03% 955
2018
Q4
$68.5M Buy
183,437
+5,971
+3% +$2.23M 0.03% 901
2018
Q3
$71.7M Buy
177,466
+5,605
+3% +$2.26M 0.03% 1042
2018
Q2
$59.3M Buy
171,861
+2,191
+1% +$756K 0.02% 1228
2018
Q1
$58.4M Buy
169,670
+2,053
+1% +$707K 0.02% 1164
2017
Q4
$63M Buy
167,617
+6,126
+4% +$2.3M 0.03% 1086
2017
Q3
$72.2M Buy
161,491
+633
+0.4% +$283K 0.03% 873
2017
Q2
$79M Buy
160,858
+1,564
+1% +$768K 0.04% 725
2017
Q1
$61.7M Buy
159,294
+4,039
+3% +$1.57M 0.03% 931
2016
Q4
$57M Sell
155,255
-900
-0.6% -$330K 0.03% 991
2016
Q3
$62.8M Buy
156,155
+14,767
+10% +$5.94M 0.03% 798
2016
Q2
$49.4M Buy
141,388
+415
+0.3% +$145K 0.03% 993
2016
Q1
$50.8M Buy
140,973
+4,526
+3% +$1.63M 0.03% 905
2015
Q4
$74.1M Buy
136,447
+7,316
+6% +$3.97M 0.05% 522
2015
Q3
$60.1M Buy
129,131
+1,926
+2% +$896K 0.04% 641
2015
Q2
$64.9M Buy
127,205
+5,032
+4% +$2.57M 0.04% 637
2015
Q1
$55.2M Buy
122,173
+1,008
+0.8% +$455K 0.03% 744
2014
Q4
$49.7M Buy
121,165
+6,226
+5% +$2.55M 0.03% 758
2014
Q3
$41.4M Sell
114,939
-14,276
-11% -$5.15M 0.03% 848
2014
Q2
$36.5M Buy
129,215
+906
+0.7% +$256K 0.03% 1000
2014
Q1
$38.5M Buy
128,309
+847
+0.7% +$254K 0.03% 867
2013
Q4
$35.1M Sell
127,462
-300
-0.2% -$82.6K 0.03% 914
2013
Q3
$40M Buy
127,762
+1,006
+0.8% +$315K 0.03% 698
2013
Q2
$28.5M Buy
+126,756
New +$28.5M 0.03% 900